Literature DB >> 16473618

Measurement of the interaction of the p85alpha subunit of phosphatidylinositol 3-kinase with Rab5.

M Dean Chamberlain, Deborah H Anderson.   

Abstract

During endocytosis of the activated platelet-derived growth factor (PDGF) receptor, phosphatidylinositol 3-kinase (PI3K) remains associated with the receptor. We found that the p85 alpha subunit of PI3 kinase binds directly to Rab5 and possesses GTPase activating protein (GAP) activity toward Rab5. Rab5 is a small monomeric GTPase involved in regulating vesicle fusion events during receptor-mediated endocytosis. We used two methods to characterize the direct binding between Rab5 in various nucleotide-bound states and the p85 protein. In the first assay, the ability of p85 to bind to Rab5 is measured using an enzyme-linked immunosorbent assay (ELISA). The second assay is a glutathione S-transferase (GST) pull-down approach in which GST-Rab5 proteins in various nucleotide-bound states are allowed to bind p85. In both instances, bound p85 is detected using anti-p85 antibodies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16473618     DOI: 10.1016/S0076-6879(05)03047-8

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  3 in total

1.  Identification of the Rab5 binding site in p110β: assays for PI3Kβ binding to Rab5.

Authors:  Rachel S Salamon; Hashem A Dbouk; Denise Collado; Jaclyn Lopiccolo; Anne R Bresnick; Jonthan M Backer
Journal:  Methods Mol Biol       Date:  2015

2.  Rab5(Q79L) interacts with the carboxyl terminus of RUFY3.

Authors:  Hitomi Yoshida; Naoko Okumura; Yasuko Kitagishi; Naoki Shirafuji; Satoru Matsuda
Journal:  Int J Biol Sci       Date:  2010-04-04       Impact factor: 6.580

3.  Patient-derived mutations within the N-terminal domains of p85α impact PTEN or Rab5 binding and regulation.

Authors:  Paul Mellor; Jeremy D S Marshall; Xuan Ruan; Dielle E Whitecross; Rebecca L Ross; Margaret A Knowles; Stanley A Moore; Deborah H Anderson
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.